Spotlight
A selection of resources from across the Federation
Resource
Technical Brief: Designing and Delivering Inclusive, Rights-Based Sexual and Reproductive Healthcare to Transgender and Gender Diverse People
This technical brief outlines key recommendations across several sexual and reproductive health service areas to promote access to inclusive care for transgender and gender diverse people.
Most Popular This Week
Resource
|
Technical Brief: Designing and Delivering Inclusive, Rights-Based Sexual and Reproductive Healthcare to Transgender and Gender Diverse People
IPPF’s commitment to person-centred care is at the heart of its strategy, Come Together (2023–2028).
Resource
|
Sexual and gender-based violence services and programming overview brief
The International Planned Parenthood Federation (IPPF) is pleased to be share this sexual and gender-based violence services and programming overview document.
Resource
|
IPPF Storage Room poster
IPPF is pleased to be providing an important poster aimed at promoting safe and effective storage practices for medical supplies in your storage rooms.
Resource
|
IMAP Statement on the importance of ensuring abortion care after 13 weeks’ gestation
This statement was prepared by the International Medical Advisory Panel (IMAP) and approved in November 2024.
Resource
|
Youth-Led Digital Solutions to Advance CSE and Adolescent and Youth Friendly Services
Commonly dubbed “the digital generation”, young people are driving innovative digital solutions to lead critical conversations related to sexual and reproductive health, rights, and justice (SRHRJ)
Resource
|
2023 Annual Performance Report
Last year saw a relentless assault on human rights, leaving many feeling anxious and pessimistic about the prospects for people from all walks of life to come together.
Resource
|
IMAP Statement on Menopause
What is menopause? Menopause is a retrospective diagnosis: it is defined after a woman or person who can menstruate is amenorrheic for 12 months.
Resource
|
IMAP Statement on Person-centred Care for Sexually Transmitted Infections
Recognizing the significant global impact of sexually transmitted infections (STIs), this statement affirms IPPF’s commitment to people-centred STI care as a critical aspect of comprehensive sexual
Filter our resources by:
Resource
| 15 March 2018
Integration of DMPA‑SC into the method mix contributes to increased uptake of all methods of family planning
Injectable contraceptives are an increasingly popular method of family planning. They are safe, discrete, highly effective, and generally last for several months. Sayana® Press, also known as subcutaneous depot medroxyprogesterone (DMPA‑SC), is a lower‑dose formula version of the already popular injectable Depo‑Provera. DMPA‑SC combines the drug and needle in a single‑use unit, which makes it easy to transport and simple to use with little training. DMPA‑SC can be administered by community health workers (CHWs) and women themselves – potentially making injectable contraceptives available to women who can’t easily travel to clinics.
Resource
| 15 March 2018
Integration of DMPA‑SC into the method mix contributes to increased uptake of all methods of family planning
Injectable contraceptives are an increasingly popular method of family planning. They are safe, discrete, highly effective, and generally last for several months. Sayana® Press, also known as subcutaneous depot medroxyprogesterone (DMPA‑SC), is a lower‑dose formula version of the already popular injectable Depo‑Provera. DMPA‑SC combines the drug and needle in a single‑use unit, which makes it easy to transport and simple to use with little training. DMPA‑SC can be administered by community health workers (CHWs) and women themselves – potentially making injectable contraceptives available to women who can’t easily travel to clinics.
Resource
| 15 March 2018
Integration of DMPA‑SC into the method mix contributes to increased uptake of all methods of family planning
Injectable contraceptives are an increasingly popular method of family planning. They are safe, discrete, highly effective, and generally last for several months. Sayana® Press, also known as subcutaneous depot medroxyprogesterone (DMPA‑SC), is a lower‑dose formula version of the already popular injectable Depo‑Provera. DMPA‑SC combines the drug and needle in a single‑use unit, which makes it easy to transport and simple to use with little training. DMPA‑SC can be administered by community health workers (CHWs) and women themselves – potentially making injectable contraceptives available to women who can’t easily travel to clinics.
Resource
| 15 March 2018
Integration of DMPA‑SC into the method mix contributes to increased uptake of all methods of family planning
Injectable contraceptives are an increasingly popular method of family planning. They are safe, discrete, highly effective, and generally last for several months. Sayana® Press, also known as subcutaneous depot medroxyprogesterone (DMPA‑SC), is a lower‑dose formula version of the already popular injectable Depo‑Provera. DMPA‑SC combines the drug and needle in a single‑use unit, which makes it easy to transport and simple to use with little training. DMPA‑SC can be administered by community health workers (CHWs) and women themselves – potentially making injectable contraceptives available to women who can’t easily travel to clinics.
